Chemotherapy-induced peripheral neuropathy in cancer patients – A four arm randomized trial on the effectiveness of electro-acupuncture

Not Applicable

• Conditions: G63.1; Polyneuropathy in neoplastic disease

• Registration Number: DRKS00004448
• Lead Sponsor: Klinik für Tumorbiologie an der Albert Ludwigs Universität Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2003-02-07
• Study Start: 2012-10-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

cancer patients, who are in remission after chemotherapy with taxanes, platinum derivatives or vinca -alkaloids and who present with symptoms of CIP

Exclusion Criteria

progressive cancer

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
change of subjective CIPN complaints, measured on a numerical rating scale (NRS 0-10) at day 0 (begin of treatment), at day 21 (end of treatment), and at day 84 (follow up 12 weeks after begin of treatment).

Secondary Outcome Measures

Name	Time	Method
europhysiological measures (Distal motor latency and Nerve conduction velocity) and Quality of life (EORTC QLQ C30) at day 0 (begin of treatment) and at day 21 (end of treatment).